Elevated Epstein-Barr virus loads and lower antibody titers in competitive athletes

Journal of Medical Virology

Volumn 82, Issue 3, 2010, Pages 446-451

  Hoffmann, Dieter ^a   Wolfarth, Bernd ^a   Hörterer, Hubert G ^a   Halle, Martin ^a   Reichhuber, Christine ^b   Nadas, Korinna ^a   Tora, Catrin ^a   Erfle, Volker ^a   Protzer, Ulrike ^a   Schätzl, Hermann M ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b MIKROGEN GMBH   (Germany)

Author keywords

Chronic infection; EBV; Performance training; Primary infection; Reactivation

Indexed keywords

IMMUNOGLOBULIN G; VIRUS ANTIBODY; VIRUS DNA;

ADULT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; ATHLETE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPSTEIN BARR VIRUS; FEMALE; FOLLOW UP; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOBLOTTING; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; PERFORMANCE; PERIPHERAL LYMPHOCYTE; PREVALENCE; PRIMARY INFECTION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SPORT; TRAINING; VIRUS LOAD; VIRUS REACTIVATION; VIRUS REPLICATION;

ADOLESCENT; ADULT; ANTIBODIES; ATHLETES; CARRIER STATE; CASE-CONTROL STUDIES; DNA, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOBLOTTING; LEUKOCYTES; MALE; POLYMERASE CHAIN REACTION; VIRAL LOAD; YOUNG ADULT;

HERPESVIRIDAE; HUMAN HERPESVIRUS 4;

EID: 75449114079     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21704     Document Type: Article

References (21)

1. Babcock GJ, Decker LL, Freeman RB, Thorley-Lawson DA. 1999. Epstein-barr virus-infected restingmemory B cells, not proliferating lymphoblasts, accumulate in the peripheral blood of immunosuppressed patients. J Exp Med 190:567-576.
2. Bakker NA, Verschuuren EA, Erasmus ME, Hepkema BG, Veeger NJ, Kallenberg CG, van der Bij W. 2007. Epstein-Barr virus-DNA load monitoring late after lung transplantation: A surrogate marker of the degree of immunosuppression and a safe guide to reduce immunosuppression. Transplantation 83:433-438.
3. Dehee A, Asselot C, Piolot T, Jacomet C, Rozenbaum W, Vidaud M, Garbarg-Chenon A, Nicolas JC. 2001. Quantification of Epstein-Barr virus load in peripheral blood of human immunodeficiency virus-infected patients using real-time PCR. J Med Virol 65:543-552.
4. Friman G, Wesslen L. 2000. Special feature for the Olympics: Effects of exercise on the immune system: Infections and exercise in high-performance athletes. Immunol Cell Biol 78:510-522.
5. Gartner BC, Kortmann K, Schafer M, Mueller-Lantzsch N, Sester U, Kaul H, Pees H. 2000. No correlation in Epstein-Barr virus reactivation between serological parameters and viral load. J Clin Microbiol 38:2458.
6. Glaser R, Friedman SB, Smyth J, Ader R, Bijur P, Brunell P, Cohen N, Krilov LR, Lifrak ST, Stone A, Toffler P. 1999. The differential impact of training stress and final examination stress on herpes-virus latency at the United States Military Academy at West Point. Brain Behav Immun 13:240-2251.
7. Gleeson M, McDonald WA, Cripps AW, Pyne DB, Clancy RL, Fricker PA. 1995. The effect on immunity of long-term intensive training in elite swimmers. Clin Exp Immunol 102:210-216.
8. Gleeson M, McDonald WA, Pyne DB, Cripps AW, Francis JL, Fricker PA, Clancy RL. 1999. Salivary IgA levels and infection risk in elite swimmers. Med Sci Sports Exerc 31:67-73.
9. Gleeson M, Pyne DB, Austin JP, Lynn Francis J, Clancy RL, McDonald WA, Fricker PA. 2002. Epstein-Barr virus reactivation and upper-respiratory illness in elite swimmers. Med Sci Sports Exerc 34:411-417.
10. Holmes MV, Caplin B, Atkinson C, Smith C, Harber M, Sweny P, Haque T. 2009. Prospective monitoring of Epstein-Barr virus DNA in adult renal transplant recipients during the early posttransplant period: role of mycophenolate mofetil. Transplantation 87:852-856.
11. Kimura H, Morita M, Yabuta Y, Kuzushima K, Kato K, Kojima S, Matsuyama T, Morishima T. 1999. Quantitative analysis of Epstein-Barr virus load by using a real-time PCR assay. J Clin Microbiol 37:132-136.
12. Luderer R, Kok M, Niesters HG, Schuurman R, de Weerdt O, Thijsen SF. 2005. Real-time Epstein-Barr virus PCR for the diagnosis of primary EBV infections and EBV reactivation. Mol Diagn 9:195-200.
13. Maurmann S, Fricke L, Wagner HJ, Schlenke P, Hennig H, Steinhoff J, Jabs WJ. 2003. Molecular parameters for precise diagnosis of asymptomatic Epstein-Barr virus reactivation in healthy carriers. J Clin Microbiol 41:5419-5428.
14. Mehta SK, Pierson DL, Cooley H, Dubow R, Lugg D. 2000. Epstein-Barr virus reactivation associated with diminished cell-mediated immunity in antarctic expeditioners. J Med Virol 61:235-240.
15. Mueller O, Villiger B, O'Callaghan B, Simon HU. 2001. Immunological effects of competitive versus recreational sports in cross-country skiing. Int J Sports Med 22:52-59.
16. Nadal D, Blasius M, Niggli FK, Meier G, Berger C. 2002. Epstein-Barr virus (EBV) DNA levels in palatine tonsils and autologous serum from EBV carriers. J Med Virol 67:54-58.
17. Pottgiesser T, Wolfarth B, Schumacher YO, Bauer G. 2006. Epstein-Barr virus serostatus: No difference despite aberrant patterns in athletes and control group. Med Sci Sports Exerc 38:1782-1791.
18. Pyne DB, Baker MS, Fricker PA, McDonald WA, Telford RD, Weidemann MJ. 1995. Effects of an intensive 12-wk training program by elite swimmers on neutrophil oxidative activity. Med Sci Sports Exerc 27:536-542.
19. Reid VL, Gleeson M, Williams N, Clancy RL. 2004. Clinical investigation of athletes with persistent fatigue and/or recurrent infections. Br J Sports Med 38:42-45.
20. Spence L, Brown WJ, Pyne DB, Nissen MD, Sloots TP, McCormack JG, Locke AS, Fricker PA. 2007. Incidence, etiology, and symptomatology of upper respiratory illness in elite athletes. Med Sci Sports Exerc 39:577-586.
21. Woods J, Lu Q, Ceddia MA, Lowder T. 2000. Special feature for the Olympics: Effects of exercise on the immune system: Exercise induced modulation of macrophage function. Immunol Cell Biol 78:545-553.